Project ideas from Hacker News discussions.

Omega-3 is inversely related to risk of early-onset dementia

📝 Discussion Summary (Click to expand)

Three dominant threads in the discussion

# Theme Key points & representative quotes
1 Where to get the “real” omega‑3s and how well the body uses them “Abstract says blood levels objectively reflect dietary intake.” – cpncrunch
“It’s always a stretch… takes something like 15x more ALA to convert to DHA.” – mikeyouse
“Algal omega‑3 is the exact same omega‑3 in fish.” – Faelon
2 How to interpret the evidence – observational vs. RCT, correlation vs. causation “Observational studies like these are useful for guiding future research, but on their own they’re essentially useless for informing lifestyle changes.” – tfirst
“The non‑DHA omega‑3 EPA are good at preventing perivascular fibrosis…” – mobilejdral (illustrating mechanistic speculation)
3 Evolutionary/biological framing of modern diet choices “I want to be alive – I don’t want supplements to replace food.” – dotancohen
“Diet is one of the very few places where your genetic ancestry actually matters.” – wizzwizz4

These three themes capture the bulk of the conversation: the practical debate over sources and conversion of omega‑3s, the skepticism about how much weight to give current studies, and the framing of dietary choices through an evolutionary lens.


🚀 Project Ideas

Omega‑Insight: Personal Omega‑3 Tracker

Summary

  • Tracks daily fish, plant, and supplement intake and estimates blood DHA/EPA/ALA levels using conversion models.
  • Provides personalized dosage recommendations, cost comparisons, and alerts for low levels.
  • Core value: turns vague “eat more fish” advice into actionable, data‑driven guidance.

Details

Key Value
Target Audience Health‑conscious individuals, vegans, seniors, clinicians
Core Feature Intake logging → blood‑level estimation → personalized supplement plan
Tech Stack React Native, Node.js, PostgreSQL, FHIR API integration, ML model (Python)
Difficulty Medium
Monetization Revenue‑ready: $4.99/month + premium lab‑integration add‑on

Notes

  • Users complain: “I don’t know if I need supplements” and “I’m not sure how much ALA converts to DHA.”
  • HN commenters want “practical guidance” and “cost‑effective” solutions.
  • The app can spark discussion on how diet vs supplements affect health outcomes.

Algae‑Direct: Transparent Algal Omega‑3 Marketplace

Summary

  • Connects certified algae cultivators with consumers, offering lab‑verified DHA/EPA profiles and transparent pricing.
  • Core value: reduces cost, eliminates middle‑man, and builds trust through third‑party testing.

Details

Key Value
Target Audience Vegan consumers, supplement brands, health‑food retailers
Core Feature Marketplace + lab‑testing pipeline + subscription delivery
Tech Stack Shopify + custom API, AWS Lambda, Docker, blockchain for provenance
Difficulty High
Monetization Revenue‑ready: 15% marketplace fee + $5/month subscription for premium analytics

Notes

  • Commenters note algal oil is “expensive” and “often diluted.”
  • “I want to skip the middle man” and “no fish killed” are recurring themes.
  • The platform can become a go‑to for ethically minded shoppers and a discussion hub for sourcing quality.

OmegaRisk: Insurance‑Ready Omega‑3 Analytics

Summary

  • SaaS that ingests blood‑test data, calculates risk scores for dementia and cardiovascular disease, and integrates with underwriting systems.
  • Core value: gives insurers a data‑driven way to adjust premiums based on omega‑3 status, potentially reducing adverse selection.

Details

Key Value
Target Audience Life, disability, long‑term care insurers
Core Feature Risk model API, dashboard, compliance reporting
Tech Stack Go, PostgreSQL, TensorFlow, RESTful API, GDPR‑compliant data storage
Difficulty High
Monetization Revenue‑ready: $10k/year per insurer + per‑claim analytics add‑on

Notes

  • “Insurance is a total market failure” and “risk pooling” are hot topics.
  • HN users discuss “pricing based on omega‑3” and potential discrimination; this tool can provide transparent, evidence‑based models.
  • Sparks debate on the ethics of using biomarker data in underwriting.

Read Later